{"speaker":{"id":3110,"title":"","firstname":"Joshua","middleinitial":"","lastname":"Smith","description":"Cancer fighter","whotheyare":"Motivated by his wife's bout with cancer, IBM's Joshua Smith applies his engineering expertise to early diagnosis.","whylisten":"<p>As a research scientist and technical team lead for IBM&#39;s Nanobiotechnology Program, Dr. Joshua Smith researches innovative healthcare technologies at the intersection of engineering and biology to better understand disease progression.<\/p><p>Smith&#39;s team recently developed a chip-based solution that can rapidly isolate biomarkers as small as 20 nanometers to help identify cancer development even before symptoms occur. He is a&nbsp;sought-after speaker on the subject of lab-on-a-chip applications for healthcare and his work has been highlighted by Forbes, CNN Money, IEEE Spectrum and Pharma Technology Focus, among other media outlets. As a Research Staff Member and IBM Master Inventor, Smith has co-authored more than a dozen peer-reviewed scientific publications and is a co-inventor of more than 30 issued patents.<\/p><p>Currently, Smith is focusing on the development of a suite of core capabilities to manipulate, separate and detect individual macromolecules, providing a technological backbone for automation in sample preparation, diagnostics and therapeutics. When not with his colleagues in the lab, Smith enjoys teaching tomorrow&#39;s researchers and engineers at Columbia University.\u202f<\/p><div><br \/><\/div>","slug":"joshua_smith","published_at":"2016-11-08 21:02:00","updated_at":"2017-02-08 15:58:13"}}